STOCK TITAN

First Shoulder Arthroplasty Surgeries Using Stryker’s Blueprint® Mixed Reality Guidance System Completed at Mayo Clinic in Minnesota and at St. Joseph’s Health Care London in Canada

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Stryker (SYK) announces successful completion of the first shoulder arthroplasty surgeries using Blueprint Mixed Reality (MR) Guidance, a new tool for surgeons to execute pre-operative plans with 3D imaging and operate with more precision and consistency.
Positive
  • None.
Negative
  • None.

Insights

Introduction of the Blueprint Mixed Reality (MR) Guidance System by Stryker signifies a notable advancement in the field of orthopedic surgery, specifically shoulder arthroplasty. The system's integration with Microsoft HoloLens™ 2 headset and Stryker's proprietary software exemplifies the ongoing trend of digital transformation in healthcare, where augmented reality (AR) is beginning to play a pivotal role in surgical procedures. The technology's ability to provide 3D imaging and real-time guidance widgets during surgery could potentially lead to more accurate implant placements, thereby reducing the risk of revision surgeries and improving patient outcomes.

From a business perspective, this innovation could enhance Stryker's competitive edge in the medical technology market. The FDA clearance of the MR Guidance system in January 2023 and its successful use by surgeons suggests readiness for wider adoption, which could drive demand for Stryker's products. However, the cost of integrating such advanced technology and training requirements could influence the rate of adoption among healthcare providers. The long-term benefits, including potential cost savings from reduced complications and improved surgical precision, may justify the initial investment.

For stakeholders, the implications are multifaceted. Hospitals and surgical centers investing in this technology could see improved patient satisfaction scores and a stronger reputation for cutting-edge care. For patients, the promise of personalized, precise surgical care could be a strong draw. However, the impact on Stryker's stock will depend on the system's market penetration and the company's ability to scale its production and distribution efficiently.

The release of Stryker's Blueprint MR Guidance System represents a significant innovation in the orthopedic device market, a sector that is keen on adopting technologies that enhance surgical precision and patient-specific treatment. The system's use of mixed reality for surgical planning and execution is likely to set a new standard for competitors, potentially catalyzing a wave of technological advancements across the industry.

Market response to such advancements typically includes increased interest from investors seeking growth in the med-tech sector, as well as from hospitals and clinics looking to differentiate themselves through state-of-the-art equipment. The system's ability to improve surgical outcomes could also lead to broader insurance coverage, further driving market growth. However, the adoption curve may be gradual, as medical professionals require training and must demonstrate the system's cost-effectiveness.

Considering the existing footprint of over 3,500 shoulder replacement procedures using the previous Blueprint Mixed Reality OR Visualization, the new MR Guidance System is poised to build on that foundation, potentially increasing Stryker's market share in orthopedic surgery. The success of this technology could also lead to its application in other types of surgical procedures, opening new revenue streams for Stryker.

Blueprint Mixed Reality Guidance System for shoulder arthroplasty offers surgeons a new tool to execute their pre-operative plan using 3D imaging and operate with more precision and consistency

KALAMAZOO, Mich.--(BUSINESS WIRE)-- Stryker (NYSE:SYK), one of the world’s leading medical technology companies, today announced that the first shoulder arthroplasty surgeries using Blueprint® Mixed Reality (MR) Guidance have been successfully completed by Dr. Joaquin Sanchez-Sotelo, MD, PhD, Consultant and Professor of Orthopedic Surgery at Mayo Clinic in Rochester, Minn., and Dr. George Athwal at St. Joseph’s Health Care London, Canada.

Stryker's Blueprint MR Guidance allows surgeons and their instruments to be ‘guided’ by 3D images and guidance widgets, which can be displayed on the patient and in the surgeon’s line of sight without disrupting normal workflow. (Photo: Business Wire)

Stryker's Blueprint MR Guidance allows surgeons and their instruments to be ‘guided’ by 3D images and guidance widgets, which can be displayed on the patient and in the surgeon’s line of sight without disrupting normal workflow. (Photo: Business Wire)

“Mixed reality technology offers important benefits to patients,” said Dr. Sanchez-Sotelo, one of the Blueprint design surgeons. “This technology allows the surgeon to plan and execute the surgery based on precise images of the patient’s shoulder, thereby minimizing the risk of improper placement of the implant. This is individualized care tailored to each patient’s anatomy.”

Designed by a team of world-class surgeons, the Blueprint MR Guidance System combines Stryker's innovative software with the Microsoft HoloLens™ 2* headset, allowing the surgeon to track the position and orientation of surgical instrumentation in the physical environment. Blueprint MR Guidance allows surgeons and their instruments to be ‘guided’ by 3D images and guidance widgets, which can be displayed on the patient and in the surgeon’s line of sight without disrupting normal workflow. The MR Guidance system received FDA clearance in January 2023.

“The addition of Mixed Reality Guidance to our Blueprint platform has the potential to benefit the entire shoulder arthroplasty market – surgeons and patients alike,” said Tim Lanier, president of Stryker’s Trauma & Extremities division. “Now that Mixed Reality Guidance has officially entered the operating room, our surgeons will have access to the most innovative technology available, enabling more precise surgical results and allowing for improved results for patients.”

Blueprint Mixed Reality OR Visualization, the previous iteration of Stryker’s Blueprint Mixed Reality, has been used by over 50 surgeons and in more than 3,500 shoulder replacement procedures globally. To learn more about Blueprint and Mixed Reality, visit shoulderblueprint.com.

Stryker anticipates the completion of the first case utilizing the Blueprint® Mixed Reality (MR) Guidance System in Europe in February, marking a significant milestone in advancing surgical technology globally.

About Stryker

Stryker is a global leader in medical technologies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in MedSurg, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com.

____________

Mayo Clinic has a financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.

Dr. Joaquin Sanchez-Sotelo is a paid consultant of Stryker Trauma and Extremities. The opinions expressed by Dr. Joaquin Sanchez-Sotelo are those of Dr. Joaquin Sanchez-Sotelo and not necessarily those of Stryker. Individual experiences may vary.

A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any product before using it in surgery.

The information presented is intended to demonstrate the breadth of Stryker’s product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any of Stryker’s products. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your sales representative if you have questions about the availability of products in your area.

Stryker Corporation or its divisions or other corporate affiliated entities own, use or have applied for the following trademarks or service marks: Stryker. All other trademarks are trademarks of their respective owners or holders.

Content ID: AP-017097A
Copyright © 2024 Stryker

* Used with permission from Microsoft

Andrea Sampson

President/CEO, Sampson Public Relations Group

asampson@sampsonprgroup.com

562.304.0301

Source: Stryker

FAQ

What is the name of the company mentioned in the press release about the new shoulder arthroplasty guidance system?

Stryker (SYK) is the company mentioned in the press release about the new shoulder arthroplasty guidance system.

What is the new tool for surgeons mentioned in the press release?

The new tool for surgeons mentioned in the press release is the Blueprint Mixed Reality (MR) Guidance System.

Who successfully completed the first shoulder arthroplasty surgeries using the Blueprint MR Guidance?

Dr. Joaquin Sanchez-Sotelo, MD, PhD, Consultant and Professor of Orthopedic Surgery at Mayo Clinic in Rochester, Minn., and Dr. George Athwal at St. Joseph’s Health Care London, Canada successfully completed the first shoulder arthroplasty surgeries using the Blueprint MR Guidance.

When did the MR Guidance system receive FDA clearance?

The MR Guidance system received FDA clearance in January 2023.

How many surgeons have used the previous iteration of Stryker’s Blueprint Mixed Reality?

Over 50 surgeons have used the previous iteration of Stryker’s Blueprint Mixed Reality.

Stryker Corporation

NYSE:SYK

SYK Rankings

SYK Latest News

SYK Stock Data

138.80B
360.31M
5.38%
80.47%
1.12%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
PORTAGE